This topic contains a solution. Click here to go to the answer

Author Question: You are assessing a patient who has suffered blunt trauma to the chest and has distended neck ... (Read 28 times)

RYAN BANYAN

  • Hero Member
  • *****
  • Posts: 563
You are assessing a patient who has suffered blunt trauma to the chest and has distended neck
  veins, blue skin, and bulging eyes. Which of the following should you most likely suspect?
 
  A. Tamponade of the lungs
  B. Retrograde circulation
  C. Traumatic asphyxia
  D. Vascular collapse

Question 2

Allowing a patient's body temperature to increase by preventing further heat loss is referred to as which of the following?
 
  A) Active rewarming B) Passive rewarming
  C) Core rewarming D) Natural rewarming



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Toya9913

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

C

Answer to Question 2

B




RYAN BANYAN

  • Member
  • Posts: 563
Reply 2 on: Jul 2, 2018
Thanks for the timely response, appreciate it


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library